First-Line Treatment for Primary Breast Diffuse Large B-Cell Lymphoma Using Immunochemotherapy and Central Nervous System Prophylaxis: A Multicenter Phase 2 Trial

First-Line Treatment for Primary Breast Diffuse Large B-Cell Lymphoma Using Immunochemotherapy and Central Nervous System Prophylaxis: A Multicenter Phase 2 Trial

There are limited data from prospective controlled trials regarding optimal treatment strategies in patients with primary breast diffuse large B-cell lymphoma (DLBCL). In this phase 2 study (NCT01448096), we examined the efficacy and safety of standard immunochemotherapy and central nervous system (...

Full description

Bibliographic Details
Main Authors: Ho-Young Yhim, Dok Hyun Yoon, Seok Jin Kim, Deok-Hwan Yang, Hyeon-Seok Eom, Kyoung Ha Kim, Yong Park, Jin Seok Kim, Hyo Jung Kim, Cheolwon Suh, Won Seog Kim, Jae-Yong Kwak
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:Cancers
Subjects:
central nervous system
diffuse large B-cell lymphoma
primary breast lymphoma
prophylaxis
rituximab
Online Access:https://www.mdpi.com/2072-6694/12/8/2192

Internet

https://www.mdpi.com/2072-6694/12/8/2192

Similar Items